Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
Lineage Cell Therapeutics, Inc. (BTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
8-K
| Quarterly results|
Docs:
|
"LINEAGE CELL THERAPEUTICS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS June 30, 2023 December 31, 2022 ASSETS CURRENT ASSETS Cash and cash equivalents $ 33,886 $ 11,355 Marketable securities 12,039 46,520 Accounts receivable, net 443 297 Prepaid expenses and other current assets 2,123 1,828 Total current assets 48,491 60,000 NONCURRENT ASSETS Property and equipment, net 5,310 5,673 Deposits and other long-term assets 588 627 Goodwill 10,672 10,672 Intangible assets, net 46,627 46,692 TOTAL ASSETS $ 111,688 $ 123,664 LIABILITIES AND SHAREHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable and accrued liabilities $ 4,685 $ 8,608 Lease liabilities, current portion 933 916 Financing lease, current portion 54 36 Deferred revenues 10,379 9,421 Other current liabilities 1 - Total..." |
|
| 05/18/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 05/11/2023 |
8-K
| Quarterly results|
Docs:
|
"LINEAGE CELL THERAPEUTICS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS March 31, 2023 December 31, 2022 ASSETS CURRENT ASSETS Cash and cash equivalents $ 15,451 $ 11,355 Marketable securities 31,363 46,520 Accounts receivable, net 203 297 Prepaid expenses and other current assets 2,638 1,828 Total current assets 49,655 60,000 NONCURRENT ASSETS Property and equipment, net 5,584 5,673 Deposits and other long-term assets 635 627 Goodwill 10,672 10,672 Intangible assets, net 46,659 46,692 TOTAL ASSETS $ 113,205 $ 123,664 LIABILITIES AND SHAREHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable and accrued liabilities $ 5,252 $ 8,608 Lease liabilities, current portion 912 916 Financing lease, current portion 51 36 Deferred revenues 11,009 9,421 Other current liabilities 1 - Tota..." |
|
| 03/09/2023 |
8-K
| Quarterly results|
Docs:
|
"LINEAGE CELL THERAPEUTICS, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS December 31, 2022 December 31, 2021 ASSETS CURRENT ASSETS Cash and cash equivalents $ 11,355 $ 55,742 Marketable securities 46,520 2,616 Accounts and grants receivable, net 297 50,840 Prepaid expenses and other current assets 1,828 2,351 Total current assets 60,000 111,549 NONCURRENT ASSETS Property and equipment, net 5,673 4,872 Deposits and other long-term assets 627 630 Goodwill 10,672 10,672 Intangible assets, net 46,692 46,822 TOTAL ASSETS $ 123,664 $ 174,545 LIABILITIES AND SHAREHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable and accrued liabilities $ 8,608 $ 27,969 Lease liabilities, current portion 916 801 Financing lease, current portion 36 30 Deferred revenues 9,421 18,119 Liability classified warra..." |
|
| 01/23/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 11/10/2022 |
8-K
| Quarterly results |
| 10/31/2022 |
8-K
| Quarterly results |
| 10/28/2022 |
8-K
| Quarterly results |
| 09/26/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/11/2022 |
8-K
| Quarterly results |
| 07/07/2022 |
8-K
| Quarterly results |
| 06/17/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Quarterly results |
| 03/10/2022 |
8-K
| Quarterly results |
| 02/14/2022 |
8-K
| Other Events Interactive Data |
| 12/21/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 12/20/2021 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
| 12/13/2021 |
8-K
| Quarterly results |
| 11/10/2021 |
8-K
| Quarterly results|
Docs:
|
"LINEAGE CELL THERAPEUTICS, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS September 30, 2021 December 31, 2020 ASSETS CURRENT ASSETS Cash and cash equivalents $ 60,809 $ 32,585 Marketable equity securities 4,295 8,977 Trade accounts receivable, net 79 4 Prepaid expenses and other current assets 3,161 2,433 Total current assets 68,344 43,999 NONCURRENT ASSETS Property and equipment, net 4,728 5,630 Deposits and other long-term assets 614 616 Goodwill 10,672 10,672 Intangible assets, net 46,854 47,032 TOTAL ASSETS $ 131,212 $ 107,949 LIABILITIES AND SHAREHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable and accrued liabilities $ 6,705 $ 6,813 Lease liabilities, current portion 801 746 Financing lease, current portion 17 16 Deferred revenues 975 193 Liability classified warran..." |
|
| 09/30/2021 |
8-K
| Quarterly results |
| 09/15/2021 |
8-K
| Quarterly results |
| 08/12/2021 |
8-K
| Quarterly results |
| 07/21/2021 |
8-K
| Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits Interactive Data |
| 06/16/2021 |
8-K
| Quarterly results |
| 06/01/2021 |
8-K
| Quarterly results |
| 05/13/2021 |
8-K
| Quarterly results |
| 05/05/2021 |
8-K
| Quarterly results |
| 05/03/2021 |
8-K
| Quarterly results |
| 04/22/2021 |
8-K
| Quarterly results |
| 03/29/2021 |
8-K
| Quarterly results |
| 03/26/2021 |
8-K
| Quarterly results |
| 03/23/2021 |
8-K
| Quarterly results |
| 03/11/2021 |
8-K
| Quarterly results |
|
|
|